News

Fish Oil Doesn't Prevent A-Fib Recurrence, Study Suggests

High doses of fish oil supplements won't prevent recurrence of atrial fibrillation (AF), researchers report.

Is Herceptin Best for HER2+ Breast Cancer Patients?

Trastuzumab (Herceptin) is the best drug treatment for human epidermal growth factor receptor 2-positive breast cancer and should remain the standard of care for that type of tumor, according to new research.

First Adult Case of Enterovirus D68 Reported as Illness Reaches 40 States, DC

Forty states and the District of Columbia now have a total of 277 confirmed cases of Enterovirus D68, the severe respiratory illness that typically targets children, U.S. health officials are reporting

Opioid Guidelines for Chronic Noncancer Pain Issued by AAN

The risks of opioids outweigh their benefits for treating chronic noncancer pain such as chronic headaches, low back pain, and fibromyalgia, according to a new statement from the American Academy of Neurology (AAN).

AHA: Consider Radiation Risks of Heart Imaging Procedures

Doctors need to make sure patients understand the radiation-related risks of heart imaging tests before sending them for such procedures, a new American Heart Association scientific statement says.

Early Antibiotic Use Might Raise Obesity Risk

Children who are given broad-spectrum antibiotics before the age of 2 may face a slightly higher risk of becoming obese during childhood.

FDA Criticized Over Implanted Medical Device Approval Process

Patients are receiving medical implants that may not have been rigorously tested before or after their approval by the U.S. Food and Drug Administration, two new studies contend.

Benefits of Vitamin D3 Lacking for Patients in ICU

For critically ill patients in intensive care units (ICUs) with vitamin D deficiency, vitamin D3 treatment has minimal health benefits, according to a new study.

Beta-Blockers Equivalent in Long QT Syndrome Genotype 1

For patients with long QT syndrome (LQTS), different β-blockers are effective for reducing the risk for first cardiac event in LQT1, but only nadolol is effective in LQT2.

Spinal Cord Stimulation Feasible for Diabetic Neuropathy

For patients with painful diabetic peripheral neuropathy (PDPN), spinal cord stimulation (SCS) is a successful treatment, reports a new study.